A leader in the success game: Altamira Therapeutics Ltd (CYTO) Stock

Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]

It is likely that Altamira Therapeutics Ltd (CYTO) Stock will grow up

Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]

Is Altamira Therapeutics Ltd (CYTO) Stock Paving the Way for Earnings?

Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]

Altamira Therapeutics Ltd (NASDAQ:CYTO) Stock Price Advanced 4.05% to $1.80

Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]